SCHEMBL23309495

SCHEMBL23309495

O=C(Nc1ccc(F)c(Cl)c1)c1cc(F)nc(F)c1F

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ FADS1 O60427 1/20 0.56
▸ NPC1 O15118 3/20 0.55
▸ RAB9A P51151 3/20 0.55
▸ KMT2A Q03164 6/20 0.54
▸ SLC2A1 P11166 1/20 0.51
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ MAPT P10636 3/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ MEN1 O00255 4/20 0.50
▸ LMNA P02545 2/20 0.50
▸ NPSR1 Q6W5P4 2/20 0.50
▸ MAOB P27338 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ HTT P42858 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309531 0.89 MAOB (0.49) FADS1NPC1RAB9AKMT2ASLC2A1
SCHEMBL23309703 0.87 RAB9A (0.51) NPC1RAB9AKMT2ASMN1; SMN2L3MBTL1
SCHEMBL23309708 0.87 RAB9A (0.52) NPC1RAB9AKMT2ASMN1; SMN2LMNA
SCHEMBL23309539 0.87 NPC1 (0.52) NPC1RAB9AKMT2ASMN1; SMN2MAPT
SCHEMBL23309730 0.85 KMT2A (0.47) NPC1RAB9AKMT2ASMN1; SMN2MAPT
SCHEMBL23309557 0.85 TMPRSS4 (0.47) KMT2A
SCHEMBL23309546 0.85 NFKB1 (0.50) FADS1NPC1RAB9AKMT2AMAPT
SCHEMBL23309502 0.84 NFKB1 (0.51) FADS1NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL23309548 0.84 FADS1 (0.55) FADS1NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL23309533 0.84 ALDH1A1 (0.43) NPC1RAB9AKMT2ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL FADS1 2452/4885NPC1 412/4885RAB9A 286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback